United States· US:75929-230_3a99b74e-4a3e-5901-e063-6394a90ad954
Edarbyclor
A medicinal product containing azilsartan kamedoxomil; chlorthalidone, registered in United States by Pharma Packaging Solutions, LLC dba Tjoapack LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
- Manufacturer
- Pharma Packaging Solutions, LLC dba Tjoapack LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 2
- ndc1175929-230-03
- ndc11759292300330 TABLET in 1 BOTTLE (75929-230-03)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eff47bdb-5946-4ac0-99b4-f5352a1e7f21 GET /v1/drugs/eff47bdb-5946-4ac0-99b4-f5352a1e7f21?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "40; 25",
"substance": "AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE",
"productndc": "75929-230",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "NDA202331",
"marketing_category": "NDA"
}See everything about azilsartan kamedoxomil; chlorthalidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.